Dimethyllysergamide: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:Dimethyllysergamide}} | |||
== | == Dimethyllysergamide == | ||
[[File:DAM-57.svg|thumb|right|Chemical structure of Dimethyllysergamide]] | |||
'''Dimethyllysergamide''' (also known as '''DAM-57''') is a chemical compound belonging to the [[ergoline]] family. It is a derivative of [[lysergic acid]] and is structurally related to [[lysergic acid diethylamide]] (LSD). Dimethyllysergamide is of interest in the field of [[psychopharmacology]] due to its potential psychoactive properties. | |||
== | == Chemical Structure and Properties == | ||
==Legal Status== | Dimethyllysergamide is characterized by its ergoline backbone, which is a tetracyclic structure. The compound is a lysergamide, meaning it is an amide of lysergic acid. The chemical structure of Dimethyllysergamide includes two methyl groups attached to the nitrogen atom of the amide group, distinguishing it from other lysergamides such as LSD, which has ethyl groups instead. | ||
The legal status of | |||
== Pharmacology == | |||
The pharmacological effects of Dimethyllysergamide are not as well-studied as those of LSD. However, it is believed to interact with the [[serotonin receptor|serotonin receptors]] in the brain, similar to other compounds in the ergoline family. This interaction is thought to be responsible for its potential psychoactive effects. | |||
== Synthesis == | |||
The synthesis of Dimethyllysergamide involves the chemical modification of [[lysergic acid]]. The process typically includes the formation of the amide bond between lysergic acid and dimethylamine. This synthesis requires careful control of reaction conditions to ensure the correct formation of the desired product. | |||
== Potential Uses and Research == | |||
Research into Dimethyllysergamide is limited, but it is of interest for its potential use in [[psychedelic therapy]] and as a tool for understanding the [[neurobiology]] of consciousness. Studies on similar compounds have shown promise in treating conditions such as [[depression]] and [[post-traumatic stress disorder]] (PTSD). | |||
== Legal Status == | |||
The legal status of Dimethyllysergamide varies by country. In many places, it is not specifically scheduled, but it may be considered an analogue of LSD and thus subject to similar legal restrictions under analogue laws. | |||
== Related Pages == | |||
* [[Lysergic acid diethylamide]] | * [[Lysergic acid diethylamide]] | ||
* [[Psychedelic | * [[Ergoline]] | ||
* [[Serotonin]] | * [[Psychedelic therapy]] | ||
* [[Serotonin receptor]] | |||
[[Category:Ergolines]] | |||
[[Category:Psychedelic drugs]] | [[Category:Psychedelic drugs]] | ||
Latest revision as of 10:46, 15 February 2025
Dimethyllysergamide[edit]
Dimethyllysergamide (also known as DAM-57) is a chemical compound belonging to the ergoline family. It is a derivative of lysergic acid and is structurally related to lysergic acid diethylamide (LSD). Dimethyllysergamide is of interest in the field of psychopharmacology due to its potential psychoactive properties.
Chemical Structure and Properties[edit]
Dimethyllysergamide is characterized by its ergoline backbone, which is a tetracyclic structure. The compound is a lysergamide, meaning it is an amide of lysergic acid. The chemical structure of Dimethyllysergamide includes two methyl groups attached to the nitrogen atom of the amide group, distinguishing it from other lysergamides such as LSD, which has ethyl groups instead.
Pharmacology[edit]
The pharmacological effects of Dimethyllysergamide are not as well-studied as those of LSD. However, it is believed to interact with the serotonin receptors in the brain, similar to other compounds in the ergoline family. This interaction is thought to be responsible for its potential psychoactive effects.
Synthesis[edit]
The synthesis of Dimethyllysergamide involves the chemical modification of lysergic acid. The process typically includes the formation of the amide bond between lysergic acid and dimethylamine. This synthesis requires careful control of reaction conditions to ensure the correct formation of the desired product.
Potential Uses and Research[edit]
Research into Dimethyllysergamide is limited, but it is of interest for its potential use in psychedelic therapy and as a tool for understanding the neurobiology of consciousness. Studies on similar compounds have shown promise in treating conditions such as depression and post-traumatic stress disorder (PTSD).
Legal Status[edit]
The legal status of Dimethyllysergamide varies by country. In many places, it is not specifically scheduled, but it may be considered an analogue of LSD and thus subject to similar legal restrictions under analogue laws.
